Molluscum contagiosum (MC) is a mucocutaneous viral infection, often self-limiting but untreated lesions can often last for 2 months to 2 years. Previously intralesional measles, mumps, and rubella (MMR) vaccine has been tried for the treatment of warts but no studies exist of its use in MC. We report our experience with intralesional MMR in 22 patients of MC. The study was carried out to assess the efficacy and safety of intralesional MMR vaccine in patients of MC. We retrospectively analyzed records of patients who received intralesional MMR for MC from September 2018 to September 2019. Demographic characteristics, number, size, and site of molluscum lesions, number of MMR injections given, and response were recorded. Records of 22 patients were analyzed. There were 10 males and 12 females. The age of the patients ranged from 6 to 50 years with a mean of 19.72 ± 10.92. At the end of 12 weeks, 18 patients (81.8%) had complete clearance of lesions, with 4 patients (18.18%) having a partial response of more than 50%. No patient showed less than 50% or no response. In only one patient who had giant molluscum, postinflammatory hyperpigmentation was noted. No other adverse effect was seen in any of the patients. MMR is a safe, effective, easy to administer, time-saving, and inexpensive therapy for lesions of MC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/dth.14615 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Comparative Study of the Efficacy of Intralesional Measles Mumps Rubella (MMR) Vaccine and Auto Implantation for the Treatment of Periungual and Palmoplantar Warts: A Randomized Controlled Trial.
Indian Dermatol Online J
August 2024
Department of Dermatology, Dr. Sampurnanand Medical College, Jodhpur, Rajasthan, India.
Article Synopsis
- Warts, caused by human papillomavirus (HPV), can be treated using immunotherapy methods like the intralesional MMR vaccine and auto implantation to stimulate the immune system, leading to effective wart removal.
- A study involving 160 patients compared the two methods, with one group receiving the MMR vaccine and the other undergoing auto implantation.
- Results showed that the MMR vaccine had a higher success rate (86% excellent response) compared to auto implantation (71%), with both methods yielding low recurrence rates and minimal side effects.
Delayed Complete Clearance of Recalcitrant Warts Due to Intralesional Measles, Mumps, and Rubella: Case Report and Review.
Cureus
August 2024
Department of Dermatology, Fakeeh University Hospital, Dubai, ARE.
Warts are a prevalent skin condition that can affect people of any age. They are caused by the human papillomavirus (HPV), a double-stranded DNA virus that can cause benign and malignant lesions and remains latent in the host cells, leading to recurrences. Although warts are benign and spontaneous clearance has been reported over the years, they often cause disfigurement, tend to koebnerize, and can be transmitted to others, making adequate and timely treatment important.
View Article and Find Full Text PDFSystematic Review of Intralesional Therapies for Cutaneous Warts.
JID Innov
May 2024
Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
Article Synopsis
- Intralesional therapies for warts lack FDA approval and consensus on the best treatment, prompting a systematic review of 62 randomized controlled trials (RCTs).
- The most commonly studied therapies included the MMR vaccine, PPD, vitamin D3, and Candida antigen, with MMR showing a complete response rate of 27-90%.
- Common side effects included injection-site reactions and flu-like symptoms, and the review underscores a gap in large multi-center RCTs despite the high prevalence of warts.
Efficacy of Intralesional Antigen Versus Measles, Mumps, and Rubella Vaccine Versus Topical Podophyllin in Treatment of Resistant Genital Warts.
J Cutan Med Surg
May 2024
Departments of Dermatology, Venereology and Andrology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Background: No single treatment is ideal for genital warts with high rate of resistance using conventional modalities as topical podophyllin; however, several intralesional immunotherapies are being tested nowadays, with variable results. In this study, we compared the safety and efficacy of treating resistant and recurrent genital warts by 2 intralesional immunotherapies [ antigen and measles, mumps, and rubella (MMR) vaccine] and compared them with topical podophyllin.
Patients/methods: A total of 45 patients with resistant or recurrent genital warts were enrolled in this study.
Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study.
Sci Rep
January 2024
Department of Dermatology, Venereology and Andrology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
Molluscum contagiosum (MC) is a skin and mucous membrane infection caused by the molluscum virus (MCV). To evaluate safety and efficacy of intralesional injection of tuberculin purified protein derivative (PPD) antigen injection versus MMR (mumps, measles, rubella) antigen for the treatment of molluscum contagiosum (MC). A total of thirty clinically confirmed patients of molluscum were recruited for this trial.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!